A detailed history of Institutional & Family Asset Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 18 shares of ALKS stock, worth $635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 18 -0.0%
Holding current value
$635
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$23.37 - $28.68 $186 - $229
-8 Reduced 30.77%
18 $0
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $244 - $287
9 Added 52.94%
26 $0
Q1 2023

May 08, 2023

SELL
$25.31 - $29.02 $25 - $29
-1 Reduced 5.56%
17 $0
Q1 2022

May 11, 2022

BUY
$23.07 - $27.99 $415 - $503
18 New
18 $0

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.